Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy

Henry Hirschberg, Francisco A Uzal, David Chighvinadze, Michelle J. Zhang, Qian Peng, Steen J. Madsen

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background and Objective: Photodynamic therapy (PDT) is a local antineoplastic treatment with the potential for tumor cell specificity. PDT using either hematoporphyrin derivatives or 5-aminolevulinic acid (ALA) has been reported to induce brain edema indicating disruption of the blood-brain barrier (BBB). We have evaluated the ability of ALA-mediated PDT to open the BBB in rats. This will permit access of chemotherapeutic agents to brain tumor cells remaining in the resection cavity wall, but limit their penetration into normal brain remote from the site of illumination. Study Design/Materials and Methods: ALA-PDT was performed on non-tumor bearing inbred Fischer rats at increasing fluence levels. Contrast T1-weighted high field (3T) magnetic resonance imaging (MRI) scans were used to monitor the degree of BBB disruption which could be inferred from the intensity and volume of the contrast agent visualized. Results: PDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. A similar increased contrast volume was observed with increasing fluence rates. The BBB was found to be disrupted 2 hours following PDT and 80-100% restored 72 hours later at the lowest fluence level. No effect on the BBB was observed if 26 J of light was given in the absence of ALA. Conclusion: ALA-PDT was highly effective in opening the BBB in a localized region of the brain. The degradation of the BBB was temporary in nature at fluence levels of 9 J, opening rapidly following treatment and significantly restored during the next 72 hours. No signs of tissue damage were seen on histological sections at this fluence level. However, higher fluences did demonstrate permanent tissue changes localized in the immediate vicinity of the light source.

Original languageEnglish (US)
Pages (from-to)535-542
Number of pages8
JournalLasers in Surgery and Medicine
Volume40
Issue number8
DOIs
StatePublished - Oct 2008

Fingerprint

Aminolevulinic Acid
Photochemotherapy
Blood-Brain Barrier
Hematoporphyrin Derivative
Light
Brain Edema
Inbred F344 Rats
Brain
Lighting
Brain Neoplasms
Antineoplastic Agents
Contrast Media
Magnetic Resonance Imaging
Therapeutics

Keywords

  • Brain edema
  • Fischer rat
  • Fluence
  • Fluence rate
  • Magnetic resonance imaging
  • Malignant glioma

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. / Hirschberg, Henry; Uzal, Francisco A; Chighvinadze, David; Zhang, Michelle J.; Peng, Qian; Madsen, Steen J.

In: Lasers in Surgery and Medicine, Vol. 40, No. 8, 10.2008, p. 535-542.

Research output: Contribution to journalArticle

Hirschberg, H, Uzal, FA, Chighvinadze, D, Zhang, MJ, Peng, Q & Madsen, SJ 2008, 'Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy', Lasers in Surgery and Medicine, vol. 40, no. 8, pp. 535-542. https://doi.org/10.1002/lsm.20670
Hirschberg, Henry ; Uzal, Francisco A ; Chighvinadze, David ; Zhang, Michelle J. ; Peng, Qian ; Madsen, Steen J. / Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. In: Lasers in Surgery and Medicine. 2008 ; Vol. 40, No. 8. pp. 535-542.
@article{91ddcba66a1e45f3889d4d0d705b8cf6,
title = "Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy",
abstract = "Background and Objective: Photodynamic therapy (PDT) is a local antineoplastic treatment with the potential for tumor cell specificity. PDT using either hematoporphyrin derivatives or 5-aminolevulinic acid (ALA) has been reported to induce brain edema indicating disruption of the blood-brain barrier (BBB). We have evaluated the ability of ALA-mediated PDT to open the BBB in rats. This will permit access of chemotherapeutic agents to brain tumor cells remaining in the resection cavity wall, but limit their penetration into normal brain remote from the site of illumination. Study Design/Materials and Methods: ALA-PDT was performed on non-tumor bearing inbred Fischer rats at increasing fluence levels. Contrast T1-weighted high field (3T) magnetic resonance imaging (MRI) scans were used to monitor the degree of BBB disruption which could be inferred from the intensity and volume of the contrast agent visualized. Results: PDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. A similar increased contrast volume was observed with increasing fluence rates. The BBB was found to be disrupted 2 hours following PDT and 80-100{\%} restored 72 hours later at the lowest fluence level. No effect on the BBB was observed if 26 J of light was given in the absence of ALA. Conclusion: ALA-PDT was highly effective in opening the BBB in a localized region of the brain. The degradation of the BBB was temporary in nature at fluence levels of 9 J, opening rapidly following treatment and significantly restored during the next 72 hours. No signs of tissue damage were seen on histological sections at this fluence level. However, higher fluences did demonstrate permanent tissue changes localized in the immediate vicinity of the light source.",
keywords = "Brain edema, Fischer rat, Fluence, Fluence rate, Magnetic resonance imaging, Malignant glioma",
author = "Henry Hirschberg and Uzal, {Francisco A} and David Chighvinadze and Zhang, {Michelle J.} and Qian Peng and Madsen, {Steen J.}",
year = "2008",
month = "10",
doi = "10.1002/lsm.20670",
language = "English (US)",
volume = "40",
pages = "535--542",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy

AU - Hirschberg, Henry

AU - Uzal, Francisco A

AU - Chighvinadze, David

AU - Zhang, Michelle J.

AU - Peng, Qian

AU - Madsen, Steen J.

PY - 2008/10

Y1 - 2008/10

N2 - Background and Objective: Photodynamic therapy (PDT) is a local antineoplastic treatment with the potential for tumor cell specificity. PDT using either hematoporphyrin derivatives or 5-aminolevulinic acid (ALA) has been reported to induce brain edema indicating disruption of the blood-brain barrier (BBB). We have evaluated the ability of ALA-mediated PDT to open the BBB in rats. This will permit access of chemotherapeutic agents to brain tumor cells remaining in the resection cavity wall, but limit their penetration into normal brain remote from the site of illumination. Study Design/Materials and Methods: ALA-PDT was performed on non-tumor bearing inbred Fischer rats at increasing fluence levels. Contrast T1-weighted high field (3T) magnetic resonance imaging (MRI) scans were used to monitor the degree of BBB disruption which could be inferred from the intensity and volume of the contrast agent visualized. Results: PDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. A similar increased contrast volume was observed with increasing fluence rates. The BBB was found to be disrupted 2 hours following PDT and 80-100% restored 72 hours later at the lowest fluence level. No effect on the BBB was observed if 26 J of light was given in the absence of ALA. Conclusion: ALA-PDT was highly effective in opening the BBB in a localized region of the brain. The degradation of the BBB was temporary in nature at fluence levels of 9 J, opening rapidly following treatment and significantly restored during the next 72 hours. No signs of tissue damage were seen on histological sections at this fluence level. However, higher fluences did demonstrate permanent tissue changes localized in the immediate vicinity of the light source.

AB - Background and Objective: Photodynamic therapy (PDT) is a local antineoplastic treatment with the potential for tumor cell specificity. PDT using either hematoporphyrin derivatives or 5-aminolevulinic acid (ALA) has been reported to induce brain edema indicating disruption of the blood-brain barrier (BBB). We have evaluated the ability of ALA-mediated PDT to open the BBB in rats. This will permit access of chemotherapeutic agents to brain tumor cells remaining in the resection cavity wall, but limit their penetration into normal brain remote from the site of illumination. Study Design/Materials and Methods: ALA-PDT was performed on non-tumor bearing inbred Fischer rats at increasing fluence levels. Contrast T1-weighted high field (3T) magnetic resonance imaging (MRI) scans were used to monitor the degree of BBB disruption which could be inferred from the intensity and volume of the contrast agent visualized. Results: PDT at increasing fluence levels between 9 and 26 J demonstrated an increasing contrast flow rate. A similar increased contrast volume was observed with increasing fluence rates. The BBB was found to be disrupted 2 hours following PDT and 80-100% restored 72 hours later at the lowest fluence level. No effect on the BBB was observed if 26 J of light was given in the absence of ALA. Conclusion: ALA-PDT was highly effective in opening the BBB in a localized region of the brain. The degradation of the BBB was temporary in nature at fluence levels of 9 J, opening rapidly following treatment and significantly restored during the next 72 hours. No signs of tissue damage were seen on histological sections at this fluence level. However, higher fluences did demonstrate permanent tissue changes localized in the immediate vicinity of the light source.

KW - Brain edema

KW - Fischer rat

KW - Fluence

KW - Fluence rate

KW - Magnetic resonance imaging

KW - Malignant glioma

UR - http://www.scopus.com/inward/record.url?scp=53249113443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53249113443&partnerID=8YFLogxK

U2 - 10.1002/lsm.20670

DO - 10.1002/lsm.20670

M3 - Article

C2 - 18798293

AN - SCOPUS:53249113443

VL - 40

SP - 535

EP - 542

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 8

ER -